Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease (Q38559075)

4 September 2017

1 reference

title

Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease (English)

1 reference

non-alcoholic fatty liver

4 September 2017

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Zobair M Younossi

1

1 reference

PubMed ID

26233836

4 September 2017

Linda Henry

series ordinal

2

1 reference

4 September 2017

2 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

33

1 reference

4 September 2017

1245-1253

1 reference

4 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s40273-015-0316-5

4 September 2017

0 references

cites work

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Bariatric surgery - effects on obesity and related co-morbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Nonalcoholic fatty liver disease in lean individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The healthcare burden imposed by liver disease in aging Baby Boomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Non-alcoholic fatty liver disease in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Prevalence and associated metabolic factors of fatty liver disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Nonalcoholic fatty liver disease and aging: epidemiology to management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Predictors of health-related quality of life in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

From the metabolic syndrome to NAFLD or vice versa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-015-0316-5

Depression and anxiety in nonalcoholic steatohepatitis: is there any association?

21 January 2018

1 reference

12 December 2020

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

1 reference

12 December 2020

Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism

1 reference

12 December 2020

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease.

1 reference

12 December 2020

Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

1 reference

12 December 2020

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

1 reference

12 December 2020

Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations

1 reference

12 December 2020

Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation

1 reference

12 December 2020

10.1007/S40273-015-0316-5

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26233836